517 related articles for article (PubMed ID: 8896566)
1. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin.
Davies HG; Richter RJ; Keifer M; Broomfield CA; Sowalla J; Furlong CE
Nat Genet; 1996 Nov; 14(3):334-6. PubMed ID: 8896566
[TBL] [Abstract][Full Text] [Related]
2. Genetically determined susceptibility to organophosphorus insecticides and nerve agents: developing a mouse model for the human PON1 polymorphism.
Furlong CE; Li WF; Costa LG; Richter RJ; Shih DM; Lusis AJ
Neurotoxicology; 1998; 19(4-5):645-50. PubMed ID: 9745924
[TBL] [Abstract][Full Text] [Related]
3. Genetic and temporal determinants of pesticide sensitivity: role of paraoxonase (PON1).
Furlong CE; Li WF; Richter RJ; Shih DM; Lusis AJ; Alleva E; Costa LG
Neurotoxicology; 2000; 21(1-2):91-100. PubMed ID: 10794389
[TBL] [Abstract][Full Text] [Related]
4. The PON1 gene and detoxication.
Furlong CE; Li WF; Brophy VH; Jarvik GP; Richter RJ; Shih DM; Lusis AJ; Costa LG
Neurotoxicology; 2000 Aug; 21(4):581-7. PubMed ID: 11022865
[TBL] [Abstract][Full Text] [Related]
5. Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds.
Li WF; Costa LG; Richter RJ; Hagen T; Shih DM; Tward A; Lusis AJ; Furlong CE
Pharmacogenetics; 2000 Dec; 10(9):767-79. PubMed ID: 11191881
[TBL] [Abstract][Full Text] [Related]
6. The role of paraoxonase (PON1) in the detoxication of organophosphates and its human polymorphism.
Costa LG; Li WF; Richter RJ; Shih DM; Lusis A; Furlong CE
Chem Biol Interact; 1999 May; 119-120():429-38. PubMed ID: 10421480
[TBL] [Abstract][Full Text] [Related]
7. The Relationship between PON1 phenotype and PON1-192 genotype in detoxification of three oxons by human liver.
Mutch E; Daly AK; Williams FM
Drug Metab Dispos; 2007 Feb; 35(2):315-20. PubMed ID: 17132760
[TBL] [Abstract][Full Text] [Related]
8. Efficient hydrolysis of the chemical warfare nerve agent tabun by recombinant and purified human and rabbit serum paraoxonase 1.
Valiyaveettil M; Alamneh Y; Biggemann L; Soojhawon I; Doctor BP; Nambiar MP
Biochem Biophys Res Commun; 2010 Dec; 403(1):97-102. PubMed ID: 21040699
[TBL] [Abstract][Full Text] [Related]
9. Protective efficacy of catalytic bioscavenger, paraoxonase 1 against sarin and soman exposure in guinea pigs.
Valiyaveettil M; Alamneh Y; Rezk P; Biggemann L; Perkins MW; Sciuto AM; Doctor BP; Nambiar MP
Biochem Pharmacol; 2011 Mar; 81(6):800-9. PubMed ID: 21219877
[TBL] [Abstract][Full Text] [Related]
10. Paraoxonase and susceptibility to organophosphorus poisoning in farmers dipping sheep.
Mackness B; Durrington P; Povey A; Thomson S; Dippnall M; Mackness M; Smith T; Cherry N
Pharmacogenetics; 2003 Feb; 13(2):81-8. PubMed ID: 12563177
[TBL] [Abstract][Full Text] [Related]
11. Paraoxonase activity against nerve gases measured by capillary electrophoresis and characterization of human serum paraoxonase (PON1) polymorphism in the coding region (Q192R).
Kanamori-Kataoka M; Seto Y
Anal Biochem; 2009 Feb; 385(1):94-100. PubMed ID: 18952040
[TBL] [Abstract][Full Text] [Related]
12. Gene-environmental interactions and organophosphate toxicity.
Povey AC
Toxicology; 2010 Dec; 278(3):294-304. PubMed ID: 20156521
[TBL] [Abstract][Full Text] [Related]
13. Determination of paraoxonase (PON1) status requires more than genotyping.
Richter RJ; Furlong CE
Pharmacogenetics; 1999 Dec; 9(6):745-53. PubMed ID: 10634137
[TBL] [Abstract][Full Text] [Related]
14. Serum paraoxonase status: a major factor in determining resistance to organophosphates.
Li WF; Costa LG; Furlong CE
J Toxicol Environ Health; 1993; 40(2-3):337-46. PubMed ID: 7693961
[TBL] [Abstract][Full Text] [Related]
15. Recombinant paraoxonase 1 protects against sarin and soman toxicity following microinstillation inhalation exposure in guinea pigs.
Valiyaveettil M; Alamneh Y; Rezk P; Perkins MW; Sciuto AM; Doctor BP; Nambiar MP
Toxicol Lett; 2011 May; 202(3):203-8. PubMed ID: 21329748
[TBL] [Abstract][Full Text] [Related]
16. Human paraoxonase double mutants hydrolyze V and G class organophosphorus nerve agents.
Kirby SD; Norris JR; Richard Smith J; Bahnson BJ; Cerasoli DM
Chem Biol Interact; 2013 Mar; 203(1):181-5. PubMed ID: 23159884
[TBL] [Abstract][Full Text] [Related]
17. Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon.
Mackness B; Mackness MI; Arrol S; Turkie W; Durrington PN
Br J Pharmacol; 1997 Sep; 122(2):265-8. PubMed ID: 9313934
[TBL] [Abstract][Full Text] [Related]
18. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity.
Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H
Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656
[TBL] [Abstract][Full Text] [Related]
19. The Arg192 isoform of paraoxonase with low sarin-hydrolyzing activity is dominant in the Japanese.
Yamasaki Y; Sakamoto K; Watada H; Kajimoto Y; Hori M
Hum Genet; 1997 Nov; 101(1):67-8. PubMed ID: 9385372
[TBL] [Abstract][Full Text] [Related]
20. Genetic variability in the cytochrome P450-paraoxonase 1 (PON1) pathway for detoxication of organophosphorus compounds.
Furlong CE
J Biochem Mol Toxicol; 2007; 21(4):197-205. PubMed ID: 17936934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
